SCHEMBL8930711

SCHEMBL8930711

Nc1ncnc2c1c(-c1ccccc1)cn2C1CC(OCc2ccccc2)C1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 5/20 0.67
▸ ABL1 P00519 4/20 0.67
▸ ABL2 P42684 4/20 0.67
▸ SRC P12931 11/20 0.66
▸ IGF1R P08069 9/20 0.62
▸ INSR P06213 5/20 0.62
▸ LYN P07948 3/20 0.62
▸ RIPK2 O43353 2/20 0.62
▸ ROCK2 O75116 2/20 0.62
▸ RET P07949 2/20 0.62
▸ ACVR1 Q04771 2/20 0.62
▸ BMPR1B O00238 1/20 0.62
▸ LATS1 O95835 1/20 0.62
▸ YES1 P07947 1/20 0.62
▸ HCK P08631 1/20 0.62
▸ FECH P22830 1/20 0.62
▸ MAP2K2 P36507 1/20 0.62
▸ CSNK1E P49674 1/20 0.62
▸ MAP2K1 Q02750 1/20 0.62
▸ MAP4K2 Q12851 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23966762 0.88 RIPK2 (0.62) EGFRABL1ABL2SRCIGF1R
SCHEMBL30180719 0.88 RIPK2 (0.62) EGFRABL1ABL2SRCIGF1R
SCHEMBL30120763 0.86 IGF1R (0.49) EGFRABL1ABL2SRCIGF1R
SCHEMBL24072895 0.86 IGF1R (0.49) EGFRABL1ABL2SRCIGF1R
SCHEMBL23966752 0.86 IGF1R (0.49) EGFRABL1ABL2SRCIGF1R
SCHEMBL18925735 0.86 IGF1R (0.49) EGFRABL1ABL2SRCIGF1R
SCHEMBL30813404 0.82 IGF1R (0.47) EGFRABL1ABL2SRCIGF1R
SCHEMBL27217870 0.82 IGF1R (0.47) EGFRABL1ABL2SRCIGF1R
SCHEMBL13314317 0.81 EGFR (0.74) EGFRABL1ABL2SRCIGF1R
SCHEMBL4819138 0.80 IGF1R (0.79) EGFRABL1ABL2SRCIGF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997028161-A1 NOVEL PYRROLO[2,3-D]PYRIMIDINES AND THEIR USE AS TYROSINE KINASE INHIBITORS NOVARTIS AG (CH) 1997-08-07 — — WO disclosed
Send feedback